A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination with Vorinostat in Patients with Advanced Prostate, Renal or Urothelial Carcinoma.
Cancer medicine（2025）
Key words
genitourinary malignancies,histone deacetylase inhibitor,PD‐1 inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined